Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT04370574

Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology

Conditions: Pancreatic Neoplasms

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 200

Sponsor: University Hospital, Montpellier

Location: Uh Montpellier Montpellier Montpellier

Summary

Pancreatic ductal adenocarcinoma (PDAC) remains among cancers with a very poor prognosis (1-year survival \

Eligibility Criteria

Inclusion Criteria: * Patient with pancreatic mass and suspicion of pancreatic ductal adenocarcinoma requiring endoscopic ultrasound with fine needle biopsy Exclusion Criteria: * Vulberable person according to L1121-6 of Public health reglementation in France * Pregnant women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04370574). StuddyBuddy aggregates publicly available trial information.